As compared to previous streamlined studies with BRCA1 and BRCA2 testing in ovarian cancer patients only [12], in our study, genetic testing was performed using a multi-gene panel approach in patients with a personal history of breast and/or ovarian cancer. The gene discussed is BRCA2; the disease is ovarian carcinoma.